Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell & Gene Therapy
Biotech
B-cell therapy biotech Walking Fish closes down
Walking Fish CEO Rusty Williams said the biotech was on the precipice of raising more capital before a key internal investor backed out.
Max Bayer
May 7, 2024 5:30pm
Young participant in Pfizer's DMD gene therapy trial dies
May 7, 2024 4:29pm
Vertex files FDA ask for next-gen cystic fibrosis candidate
May 7, 2024 7:30am
Astellas hops into Poseida's car for $50M cell therapy collab
May 1, 2024 12:49pm
Labcorp nets companion Dx OK for Pfizer hemophilia gene therapy
Apr 29, 2024 1:56pm
BMS closes Redwood City cell therapy research site
Apr 26, 2024 10:59am
More News
BioMarin axes 4 candidates, centers R&D around 3 assets
Apr 25, 2024 10:10am
Regeneron signs Mammoth gene editing deal worth $100M upfront
Apr 25, 2024 8:49am
Genentech axes $3B Adaptimmune cell therapy deal
Apr 12, 2024 11:22am
Poseida examines CAR-T conditioning to crack into solid tumors
Apr 10, 2024 10:32am
See more stories